Pearl River Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History

Pearl River Capital’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-6,213	Closed	-$372K	–	794
2019 Q4	$372K	Buy	+6,213	New	+$233K	0.14%	267
2019 Q1	–	Sell	-1,046	Closed	-$22K	–	968
2018 Q4	$22K	Buy	+1,046	New	+$27K	0.1%	269

Pearl River Capital's BOLD Position: Q1 2020 in Review

Pearl River Capital sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 6,213 shares — an estimated $372K sold.

Pearl River Capital first reported a position in BOLD in Q4 2018 and held it in 2 quarters. The position peaked at $372K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Pearl River Capital reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Pearl River Capital sold 6,213 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $372K.
Pearl River Capital first reported a position in Audentes Therapeutics, Inc in Q4 2018 and held it in 2 quarters.
Pearl River Capital's Audentes Therapeutics, Inc position peaked at $372K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Pearl River Capital's 13F filing for Q1 2020, filed 6 May 2020.